Justin Michael
Lawyers
Filters
Omnicell $575 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in a Rule 144A offering by Omnicell, Inc. of $575 million aggregate principal amount of 0.25% convertible senior notes due…
KKR $1.15 billion mandatory convertible preferred stock offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by KKR & Co. Inc. of $1.15 billion aggregate principal amount of its 6.000% Series C Mandatory…
Zscaler $1.15 billion convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Zscaler, Inc. of $1.15 billion aggregate principal amount of its 0.125%…
Coupa Software $1.38 billion convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coupa Software Incorporated of $1.38 billion aggregate principal amount of…
HubSpot $460 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by HubSpot, Inc. of $460 million aggregate principal amount of its 0.375% convertible senior notes due 2025…
Datadog $747.5 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Datadog, Inc. of $747.5 million aggregate principal amount of its 0.125%…
Inphi $506 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Inphi Corporation of $506 million aggregate principal amount of its 0.75%…
Nevro $346 million concurrent offerings of stock and convertible senior notes
Davis Polk advised the sole book-running manager in connection with the SEC-registered offering by Nevro Corp. of $189.75 million aggregate principal amount of its 2.75% convertible…
Revance Therapeutics $287.5 million convertible senior notes offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…
SMART Global Holdings $250 million convertible senior notes offering
Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…